ResMed (RMD) has drawn fresh attention after recent price moves left the stock roughly flat over the past month but ahead over the past 3 months, prompting investors to reassess its longer term performance profile
Over the past year, momentum in ResMed has cooled, with a year-to-date share price return that is down 2.16%. This is in contrast to the 3-year total shareholder return of 63.08%, which still points to a much stronger historical run than the more recent 1-year total shareholder return, which is down 1.04%
Scan beyond ResMed and see how other hand-picked healthcare leaders stack up on quality and value in the 38 healthcare AI stocks
ResMed’s share price has paused after a strong few years, so the key question now is whether to invest at today’s level or wait for a clearer markdown before gaining exposure
Most Popular Narrative: 10% Undervalued
ResMed’s last close of $239.53 sits below the analyst consensus Narrative fair value of $265.11. This frames the stock as modestly undervalued when those long term forecasts are discounted at 7.52%
Expansion of the diagnosis and treatment funnel through partnerships with consumer wearables and GLP-1 driven patient flows is bringing more previously undiagnosed sleep apnea patients into the ResMed ecosystem, which can support future device and mask revenue growth
See why 79 investors see ResMed as 10% undervalued
Result: Fair Value of $265.11 (UNDERVALUED)
Still, the Astral corrective action and the loss of MatrixCare revenue give ResMed holders two clear overhangs that could challenge this undervaluation story
Find out about the key risks to this ResMed narrative
Next Steps
Curious whether the market is being too cautious or just about right on ResMed today? Act fast on your own research and weigh the potential by reviewing the 4 key rewards
Looking for more ideas beyond ResMed?
If you want to round out your watchlist, use the Simply Wall St Screener to spot fresh ideas before they move and avoid being late to the story
- Target resilient balance sheets and steady fundamentals with a curated list of solid balance sheet and fundamentals (24 results) that helps you focus on financially robust businesses.
- Hunt for mispriced opportunities by scanning the 35 high quality undervalued stocks and see which companies the numbers suggest may be trading below their underlying strength.
- Stack potential income ideas by reviewing a 6 dividend fortresses that highlights higher yielding payers with the capacity to keep distributing cash to shareholders.
New:AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities
• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics
Have feedback on this article? Concerned about the content? Get in touch with us directly.Alternatively, email editorial-team@simplywallst.com
Weekly Picks
AU
Austin_Wynnon First Breach25 days ago
First Breach: Ammo Today. Drones Next. Why This America First Company Could Easily Double in Price
Fair Value:US$2.864.7% undervalued
56followersusers have followed this narrative
0commentsusers have commented on this narrative
9likesusers have liked this narrative
ANANTONI0on PepsiCo19 days ago
PepsiCo at $135: A 4.4% Yield, an Activist, and Why the Maths Still Says Wait for $95
Fair Value:US$144
30followersusers have followed this narrative
0commentsusers have commented on this narrative
5likesusers have liked this narrative
ANAndrei_Niculescuon Talen Energy3 days ago
Talen: Selling Tomorrow’s PJM Capacity to Buy Back Today — 2027 Guide Is Real, but So Is the Leverage and the Hedge Book
Fair Value:US$3954.8% undervalued
6followersusers have followed this narrative
0commentsusers have commented on this narrative
2likesusers have liked this narrative
COComposite_Researchon Eaton3 months ago
“Grid-to-Chip: How Eaton Controls the Physical Bottlenecks of AI Data Centers”
Fair Value:US$517.0631.7% undervalued
57followersusers have followed this narrative
3commentsusers have commented on this narrative
12likesusers have liked this narrative
Andrew Legget
Market Insights

People often treat dividend and growth investing like a fork in the road, one or the other. But dividends, a rising share price and buybacks all contribute to your total return
36
Nov 13, 2026SA
Sasha Jovanovic
Sasha is an Equity Analyst at Simply Wall St with 15 years financial markets experience. He is a CFA Charterholder and holds Bachelor degrees in Mathematics and International Studies from the University of Technology, Sydney, Australia. He worked at CommSec Investment Management as an Investment Analyst from 2014 and later at Sequoia Financial Group as a Portfolio Analyst from 2018
View Profile
About NYSE:RMD
Engages in the digital health and cloud-connected medical devices business in the United States and internationally
See The Free Research Report
Flawless balance sheet, undervalued and pays a dividend
See The Free Research Report
Similar Companies
NYSE:ABT
NYSE:MDT
Market Insights
Dividend or growth investing? It’s the wrong questionAN
Andrew Legget
What does rising cash burn mean for AI stocks?MI
Mitch Lawler
What memory stocks can teach us about cyclesAN
Andrew Legget
RecentlyUpdated Narratives
IN
Investingwillyon ETF Series Solutions – Defiance Space and Connective Tech ETFabout 4 hours ago
The 5G Fund That Grew Into a Space and AI Play
Fair Value:US$9520.9% undervalued
1followerusers have followed this narrative
0commentsusers have commented on this narrative
0likesusers have liked this narrative
RI
RISEon Manila Electricabout 5 hours ago
The Index Is Dropping Meralco. Metro Manila Cannot, and I Am Watching
Fair Value:₱46413.1% undervalued
1followerusers have followed this narrative
0commentsusers have commented on this narrative
0likesusers have liked this narrative
RI
RISEon Puregold Price Clubabout 5 hours ago
The Last Thing a Family Cuts Is the Grocery Run. That Is My Case for Puregold
Fair Value:₱53.1425.2% undervalued
1followerusers have followed this narrative
0commentsusers have commented on this narrative
0likesusers have liked this narrative

